124 related articles for article (PubMed ID: 7351056)
1. Renal effects of nitroprusside and hydralazine in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Rapaport E
Circulation; 1980 Feb; 61(2):316-23. PubMed ID: 7351056
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA; Pierpont G; Cohn JN
Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
[TBL] [Abstract][Full Text] [Related]
3. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.
Hamilton MA; Stevenson LW; Child JS; Moriguchi JD; Woo M
Am J Cardiol; 1990 May; 65(18):1209-12. PubMed ID: 2186605
[TBL] [Abstract][Full Text] [Related]
4. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Benowitz NL; Rapaport E
Circulation; 1981 Nov; 64(5):973-6. PubMed ID: 7285311
[TBL] [Abstract][Full Text] [Related]
5. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
Pierpont GL; Cohn JN; Franciosa JA
Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
[No Abstract] [Full Text] [Related]
6. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
7. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
Chatterjee K; Ports TA; Brundage BH; Massie B; Holly AN; Parmley WW
Ann Intern Med; 1980 May; 92(5):600-4. PubMed ID: 7386999
[TBL] [Abstract][Full Text] [Related]
8. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure.
Elkayam U; Weber L; Torkan B; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 May; 53(9):1321-5. PubMed ID: 6711434
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
Konstam MA; Weiland DS; Conlon TP; Martin TT; Cohen SR; Eichhorn EJ; Isner JM; Zile MR; Salem DN
Am J Cardiol; 1987 May; 59(12):1131-7. PubMed ID: 3578055
[TBL] [Abstract][Full Text] [Related]
11. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
Shepherd AM; Irvine NA
J Cardiovasc Pharmacol; 1986; 8(3):527-33. PubMed ID: 2425168
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic shifts in patients with congestive heart failure during treatment with sodium nitroprusside].
Tatishvili NI; Chkhaidze ZK; Kurashvili RB; Mamatsashvili MD; Narsiia NN
Kardiologiia; 1983 Jul; 23(7):28-31. PubMed ID: 6620808
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator therapy with a new stable prostacyclin analog, OP-41483, for congestive heart failure due to coronary artery disease and comparison of hemodynamic effects and platelet aggregation with nitroprusside.
Yui Y; Takatsu Y; Hattori R; Susawa T; Sakaguchi K; Yui N; Kawai C
Am J Cardiol; 1986 Nov; 58(10):1042-5. PubMed ID: 3535472
[TBL] [Abstract][Full Text] [Related]
14. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
15. Precipitation of heart failure following sudden withdrawal of hydralazine.
Black JR; Mehta J
Chest; 1979 Jun; 75(6):724-5. PubMed ID: 436528
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
Cerdá E; Esteban A; de la Cal MA; Fernández A; García A
Crit Care Med; 1985 Apr; 13(4):221-3. PubMed ID: 3979067
[TBL] [Abstract][Full Text] [Related]
17. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes.
Firth BG; Dehmer GJ; Markham RV; Willerson JT; Hillis LD
Am J Cardiol; 1982 Nov; 50(5):954-9. PubMed ID: 6291370
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and neurochemical determinates of renal function in chronic heart failure.
Gilbert C; Cherney DZ; Parker AB; Mak S; Floras JS; Al-Hesayen A; Parker JD
Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(2):R167-75. PubMed ID: 26561645
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
[TBL] [Abstract][Full Text] [Related]
20. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
